Ofloxacin for Typhoid Fever: Role in Enteric Fever Treatment

Ofloxacin (a fluoroquinolone) is an effective alternative for treating uncomplicated typhoid fever (Salmonella Typhi) and paratyphoid fever (S. Paratyphi A/B/C), particularly in regions with multidrug resistance (MDR) to first-line agents (ampicillin, chloramphenicol, TMP-SMX).

Current WHO/CDC Guidance

  • First-line: Ceftriaxone (IV/IM) or azithromycin (oral).
  • Fluoroquinolones (ciprofloxacin, ofloxacin): Used when susceptibility confirmed; resistance rising (especially in South Asia). Not for children/pregnancy unless benefits outweigh risks (cartilage toxicity).

Dosing (Adults)

Ofloxacin 400 mg PO/IV q12h × 7–10 days (typhoid); 5–7 days (paratyphoid).

Key Considerations

  • Culture & susceptibility essential before fluoroquinolone use.
  • Monitor for tendinopathy, QT prolongation, CNS effects, dysglycemia.
  • Resistance: gyrA/parC mutations reduce efficacy; nalidixic acid resistance predicts fluoroquinolone treatment failure.

Always follow local antibiogram and infectious disease guidance.

Prescription Medications - Related Articles